Cargando…
Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC
Brain metastasis (BM) genetically diverges from the primary tumor in non‐small‐cell lung cancer (NSCLC). Hence, accurately capturing clinically relevant alterations is pivotal for the delivery of targeted therapies. Circulating tumor DNA (ctDNA) sequencing has emerged as a promising liquid biopsy in...
Autores principales: | Wu, Jun, Liu, Zhiqiang, Huang, Tianxiang, Wang, Ying, Song, Meng Meng, Song, Tao, Long, Gretchen, Zhang, Xiaobing, Li, Xi, Zhang, Longbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158766/ https://www.ncbi.nlm.nih.gov/pubmed/36495130 http://dx.doi.org/10.1002/1878-0261.13357 |
Ejemplares similares
-
Genome‐wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis
por: Wei, Tao, et al.
Publicado: (2020) -
Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution
por: Yang, Hainan, et al.
Publicado: (2022) -
Genetic profiling of circulating cell‐free DNA from cerebrospinal fluid and paired plasma in ALK‐positive lung cancer with brain metastases
por: Shi, Liang, et al.
Publicado: (2023) -
Head-nodding: a driving force for the circulation of cerebrospinal fluid
por: Xu, Qiang, et al.
Publicado: (2021) -
Detection of circulating tumor DNA from non‐small cell lung cancer brain metastasis in cerebrospinal fluid samples
por: Ma, Chunhua, et al.
Publicado: (2020)